1. Home
  2. UAMY vs NTRB Comparison

UAMY vs NTRB Comparison

Compare UAMY & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • NTRB
  • Stock Information
  • Founded
  • UAMY 1968
  • NTRB 2016
  • Country
  • UAMY United States
  • NTRB United States
  • Employees
  • UAMY N/A
  • NTRB N/A
  • Industry
  • UAMY Metal Fabrications
  • NTRB Industrial Specialties
  • Sector
  • UAMY Industrials
  • NTRB Health Care
  • Exchange
  • UAMY Nasdaq
  • NTRB Nasdaq
  • Market Cap
  • UAMY 74.2M
  • NTRB 77.9M
  • IPO Year
  • UAMY N/A
  • NTRB N/A
  • Fundamental
  • Price
  • UAMY $1.93
  • NTRB $4.37
  • Analyst Decision
  • UAMY Strong Buy
  • NTRB
  • Analyst Count
  • UAMY 2
  • NTRB 0
  • Target Price
  • UAMY $1.75
  • NTRB N/A
  • AVG Volume (30 Days)
  • UAMY 7.2M
  • NTRB 27.6K
  • Earning Date
  • UAMY 11-12-2024
  • NTRB 12-04-2024
  • Dividend Yield
  • UAMY N/A
  • NTRB N/A
  • EPS Growth
  • UAMY N/A
  • NTRB N/A
  • EPS
  • UAMY N/A
  • NTRB N/A
  • Revenue
  • UAMY $10,219,826.00
  • NTRB $2,021,771.00
  • Revenue This Year
  • UAMY N/A
  • NTRB N/A
  • Revenue Next Year
  • UAMY N/A
  • NTRB N/A
  • P/E Ratio
  • UAMY N/A
  • NTRB N/A
  • Revenue Growth
  • UAMY 28.40
  • NTRB N/A
  • 52 Week Low
  • UAMY $0.17
  • NTRB $2.22
  • 52 Week High
  • UAMY $2.35
  • NTRB $9.60
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 74.22
  • NTRB 47.75
  • Support Level
  • UAMY $1.90
  • NTRB $3.87
  • Resistance Level
  • UAMY $2.35
  • NTRB $4.86
  • Average True Range (ATR)
  • UAMY 0.32
  • NTRB 0.48
  • MACD
  • UAMY 0.09
  • NTRB 0.08
  • Stochastic Oscillator
  • UAMY 83.60
  • NTRB 65.05

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: